COVID-19, Pregnancy & Cord Blood Banking

From Guest Blogger Karen Madden, Ph.D. – Vice President, Technology & Innovation PerkinElmer

Karen is a scientist, business development professional, mother of two, and is committed to driving innovation, pushing the boundaries of science and translating discoveries from the lab to the real world to improve women’s health.

The current coronavirus pandemic is certainly concerning to everyone, but especially to mothers and expecting mothers. Currently, it’s unknown if pregnant women have a greater chance of getting sick from the COVID-19, but because of changes in a woman’s body during pregnancy, they may be at a higher risk of viral respiratory infections.1 Because the COVID-19 outbreak is so recent there are limited publications available analyzing its impact. However, in a small case study of babies born to mothers who tested positive for SARS-CoV-2 (the virus that causes COVID-19) none of the infants tested positive and the virus was not detected in any samples of amniotic fluid.2

Read More

PerkinElmer’s Fourth Annual Impact Day

Every year, employees around the globe from ViaCord and its parent company, PerkinElmer, participate in Impact Day. Impact Day focuses on local projects supporting areas of disease research, food, the environment, and newborn health.

Read More